of MSCs in cellular
therapy. Treatment of MSCs utilizing pharmaceutical compounds,
cytokines, growth
Korytina, G.F.,
Aznabaeva, Y.G.,
Kochetova, O.V.,
Nasibullin, T.R.,
Akhmadishina, L.Z.,
Khusnutdinova, N.N.,
Zagidullin, N. Sh.,
Victorova, T.V. (2023) the association of
cytokines and inflammatory genes polymorphisms and their combinations with COPD. SNPs
Mukhametov, Ural,
Lyulin, Sergey,
Borzunov, Dmitry,
Ilyasova, Tatiana,
Gareev, Ilgiz,
Sufianov, Albert (2023) levels of
cytokines/chemokines, immunoglobulins, and circulating immune complexes was using ELISA
Chen, P.,
Yu, Y.,
Su, S.,
Du, Z.,
Cai, B.,
Sun, X.,
Chattipakorn, N.,
Samorodov, A.V.,
Pavlov, V.N.,
Tang, Q.,
Cho, W.-J.,
Liang, G. (2023) ) derivatives and evaluated their anti-inflammatory
activities by measuring the release of
cytokines